09 Feb 2023
19:00 CET |
VGP |
VGP Announces Audio Webcast to Review 2022 Financial Results
|
35101010 Real Estate Holding and Development |
Meetings / events |
09 Feb 2023
07:36 CET |
CRESCENT |
GEREGLEMENTEERDE INFORMATIE – Openbaarmaking met toepassing van artikel 15 van de Wet van 2 mei 2007 (de Transparantiewet)
|
15101010 Telecommunications Equipment |
Other subject |
09 Feb 2023
07:35 CET |
CRESCENT |
REGULATED INFORMATION – Disclosure pursuant to article 15 of the Law of May 2, 2007 (the Transparency Law)
|
15101010 Telecommunications Equipment |
Other subject |
09 Feb 2023
07:00 CET |
KBC |
KBC Group: Fourth-quarter result of 818 million euros
|
30101010 Banks |
Other subject |
09 Feb 2023
07:00 CET |
BIOCARTIS |
Press release Biocartis Group NV: Biocartis Announces the Launch of the First Assay Developed With the New Idylla™ Flex Technology
|
20101025 Health Services |
Other subject |
09 Feb 2023
07:00 CET |
KBC |
KBC Groupe: Bénéfice de 818 millions d'euros au quatrième trimestre
|
30101010 Banks |
Other subject |
09 Feb 2023
07:00 CET |
FAGRON |
Fagron rapporteert 19% omzetgroei, 11% hogere REBITDA en vrije kasstroom van €91 miljoen voor 2022
|
20102010 Medical Equipment |
Other subject |
09 Feb 2023
07:00 CET |
KBC |
KBC Groep: Resultaat vierde kwartaal van 818 miljoen euro
|
30101010 Banks |
Other subject |
09 Feb 2023
07:00 CET |
BIOCARTIS |
Persbericht Biocartis Group NV: BIOCARTIS MAAKT DE LANCERING BEKEND VAN DE EERSTE ASSAY ONTWIKKELD MET DE NIEUWE IDYLLA™ FLEX-TECHNOLOGIE
|
20101025 Health Services |
Other subject |
09 Feb 2023
07:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology annonce la publication des données de son étude clinique THINK de Phase 1 avec CYAD-01
|
20103010 Biotechnology |
Other subject |
09 Feb 2023
07:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology Announces the Publication of Data From Its Phase 1 THINK Study of CYAD-01
|
20103010 Biotechnology |
Other subject |
09 Feb 2023
07:00 CET |
FAGRON |
Fagron reports 19% topline growth, 11% increase in REBITDA and free cash flow of €91 million for 2022
|
20102010 Medical Equipment |
Other subject |
08 Feb 2023
18:24 CET |
CENERGY |
Hellenic Cables signe un nouveau projet d'interconnexion sous-marine dans la mer Adriatique.
|
50202010 Electrical Components |
News contracts |
08 Feb 2023
18:23 CET |
CENERGY |
Hellenic Cables signs a new submarine interconnection project in the Adriatic Sea
|
50202010 Electrical Components |
News contracts |
08 Feb 2023
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : Inkoop eigen aandelen
|
40204020 Clothing and Accessories |
Other subject |
08 Feb 2023
18:00 CET |
VAN DE VELDE |
VAN DE VELDE : Acquisition of treasury shares
|
40204020 Clothing and Accessories |
Other subject |
08 Feb 2023
17:46 CET |
CRESCENT |
GEREGLEMENTEERDE INFORMATIE EN VOORWETENSCHAP - Crescent kondigt herschikking van haar aandeelhouderschap aan en bevestigt een omzetstijging van meer dan 25 % over 2022
|
15101010 Telecommunications Equipment |
Other subject |
08 Feb 2023
17:45 CET |
CRESCENT |
REGULATED INFORMATION AND INSIDER INFORMATION - Crescent announces rearrangement of its shareholders’ structure and confirms revenue growth of more than 25% over 2022
|
15101010 Telecommunications Equipment |
Other subject |
08 Feb 2023
08:00 CET |
WERELDHAVE BELGIUM |
Wereldhave Belgium - Resultaten 2022
|
35102045 Retail REITs |
New |
08 Feb 2023
08:00 CET |
WERELDHAVE BELGIUM |
Wereldhave Belgium - Results 2022
|
35102045 Retail REITs |
New |
08 Feb 2023
08:00 CET |
WERELDHAVE BELGIUM |
Wereldhave Belgium - Résultats 2022
|
35102045 Retail REITs |
New |
08 Feb 2023
07:00 CET |
BIOSENIC |
BioSenic announces the approval and publication of the Prospectus for listing and admission to trading of the shares and subscription rights issued in the context of the capital increase by way of in kind contributions of Medsenic
|
20103010 Biotechnology |
Corporate life |
08 Feb 2023
07:00 CET |
BIOSENIC |
BioSenic annonce l’approbation et la publication du Prospectus de cotation et d’admission à la négociation des actions et droits de souscription émis dans le cadre de l’augmentation de capital par apport en nature de Medsenic
|
20103010 Biotechnology |
Corporate life |
07 Feb 2023
14:21 CET |
EURONAV |
UPDATE SPOEDARBITRAGE
|
50206030 Marine Transportation |
Other subject |
07 Feb 2023
14:15 CET |
EURONAV |
Update on Emergency Arbitration
|
50206030 Marine Transportation |
Other subject |
07 Feb 2023
08:05 CET |
LOTUS BAKERIES |
Lotus Bakeries 2022 Annual Results
|
45102020 Food Products |
Other subject |
07 Feb 2023
07:53 CET |
LOTUS BAKERIES |
2022 Annual Results
|
45102020 Food Products |
Commercial results |
06 Feb 2023
22:00 CET |
EURONAV |
Euronav - Bijzondere Algemene Vergadering van 23 maart 2023
|
50206030 Marine Transportation |
Other subject |
06 Feb 2023
22:00 CET |
EURONAV |
Euronav – Special General Meeting of 23 March 2023
|
50206030 Marine Transportation |
Other subject |
06 Feb 2023
18:10 CET |
GBL |
GBL - Transacties op GBL-aandelen 06-02-2023
|
30202000 Diversified Financial Services |
Other financial transaction |
06 Feb 2023
18:09 CET |
GBL |
GBL - Transactions sur actions propres 06-02-2023
|
30202000 Diversified Financial Services |
Other financial transaction |
06 Feb 2023
18:08 CET |
GBL |
GBL - Transactions on GBL shares 06-02-2023
|
30202000 Diversified Financial Services |
Other financial transaction |
06 Feb 2023
17:40 CET |
KBC ANCORA ord |
Update on share repurchase program KBC Ancora until 03 February 2023
|
30101010 Banks |
Other subject |
06 Feb 2023
17:40 CET |
KBC ANCORA ord |
Mise à jour du programme de rachat d’actions propres KBC Ancora jusqu’au 03 février 2023
|
30101010 Banks |
Other subject |
06 Feb 2023
17:40 CET |
KBC ANCORA ord |
Update inkoopprogramma KBC Ancora tot 03 februari 2023
|
30101010 Banks |
Other subject |
06 Feb 2023
08:32 CET |
TITAN CEMENT |
Programme de rachats d'actions
|
50101030 Cement |
Other subject |
06 Feb 2023
08:31 CET |
TITAN CEMENT |
Share buyback programme
|
50101030 Cement |
Other subject |
06 Feb 2023
07:19 CET |
JENSEN-GROUP |
Update: Inkoop eigen aandelen
|
50204000 Machinery: Industrial |
Other subject |
06 Feb 2023
07:18 CET |
JENSEN-GROUP |
Update: share buy back
|
50204000 Machinery: Industrial |
Other subject |
03 Feb 2023
18:35 CET |
KBC |
KBC Group: KBC Bank Ireland closes sale of substantially all of its assets and liabilities to Bank of Ireland
|
30101010 Banks |
Other subject |
03 Feb 2023
18:35 CET |
KBC |
KBC Groupe: KBC Bank Ireland clôt la vente de la quasi-totalité de ses actifs et passifs à Bank of Ireland
|
30101010 Banks |
Other subject |
03 Feb 2023
18:35 CET |
KBC |
KBC Groep: KBC Bank Ireland rondt verkoop af van vrijwel al zijn activa en verplichtingen aan Bank of Ireland
|
30101010 Banks |
Other subject |
03 Feb 2023
14:00 CET |
MDXHEALTH |
MDxHealth Announces Pricing of Offering of ADSs in the United States
|
20103010 Biotechnology |
Share introduction and issues |
03 Feb 2023
14:00 CET |
MDXHEALTH |
MDxHealth annonce la détermination du prix de l'offre d'ADSs aux États-Unis
|
20103010 Biotechnology |
Share introduction and issues |
03 Feb 2023
09:41 CET |
ATENOR |
Atenor acquires permit project UK Fleet House
|
35101010 Real Estate Holding and Development |
Commercial operations |
03 Feb 2023
08:15 CET |
BEKAERT |
Bekaert - Update over het Inkoop van Eigen Aandelen Programma en de Liquiditeitsovereenkomst
|
55102010 Iron and Steel |
Legal |
03 Feb 2023
08:15 CET |
BEKAERT |
Bekaert - Update on the Share Buyback Program and the Liquidity Agreement
|
55102010 Iron and Steel |
Legal |
03 Feb 2023
08:15 CET |
BEKAERT |
Bekaert - Mise à jour relative au Programme de Rachat d’Actions et au Contrat de Liquidité
|
55102010 Iron and Steel |
Legal |
03 Feb 2023
07:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology Provides Fourth Quarter 2022 Business Update and 2023 Outlook
|
20103010 Biotechnology |
Other subject |
03 Feb 2023
07:00 CET |
CELYAD ONCOLOGY |
Celyad Oncology publie ses résultats financiers du quatrième trimestre 2022 et ses perspectives pour 2023
|
20103010 Biotechnology |
Other subject |